Verv Revenue and Competitors
Estimated Revenue & Valuation
- Verv's estimated annual revenue is currently $4.8M per year.
- Verv's estimated revenue per employee is $116,000
Employee Data
- Verv has 41 Employees.
- Verv grew their employee count by -16% last year.
Verv Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $57.6M | 318 | 24% | N/A | N/A |
#2 | $44.6M | 286 | 23% | $25.4M | N/A |
#3 | $5.1M | 44 | -6% | N/A | N/A |
#4 | $35.1M | 225 | -3% | $46.9M | N/A |
#5 | $14.5M | 100 | 5% | N/A | N/A |
#6 | $1.3M | 15 | -6% | N/A | N/A |
#7 | $1.5M | 17 | 0% | N/A | N/A |
#8 | $2.9M | 29 | -12% | N/A | N/A |
#9 | $125.2M | 691 | 6% | N/A | N/A |
#10 | $95.9M | 529 | -1% | N/A | N/A |
What Is Verv?
Meet Verv – the new Red Rock Apps. It's just made its first appearance with a refreshed concept and a completely new look. Since its launch back in 2013, Verv has become one of the most downloaded Health & Fitness mobile app developers, with over 60 million users worldwide. Its portfolio includes 4 products with more coming this year. Through simple and effective personalized solutions, Verv helps people achieve personal goals, embrace a healthy lifestyle and live a more fulfilling life. Success of the products has been the result of a strong team effort throughout the entire journey of their development. Engineers deliver innovation, designers bring fresh twists to the look and usability, marketers find the best way to position the app knowing it from the inside out – all of this helps create truly great products. Follow the link to learn more: www.verv.com Check out our apps here: iOS: https://itunes.apple.com/us/developer/verv/id583901247 Android: https://play.google.com/store/apps/developer?id=Verv+Inc
keywords:N/A
N/A
Total Funding
41
Number of Employees
$4.8M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Verv News
Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks Investment Research to Sell. Posted by admin on Apr 22nd, 2022.
Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks Investment Research to Sell. Posted by admin on Apr 22nd, 2022.
VERV has been the subject of a number of research analyst reports. Royal Bank of Canada assumed coverage on shares of Verve Therapeutics in...
VERV has been the subject of a number of research analyst reports. Royal Bank of Canada assumed coverage on shares of Verve Therapeutics in...
Other Companies in Minsk
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 41 | 17% | N/A |
#2 | $8.4M | 42 | 14% | N/A |
#3 | $4.8M | 43 | -2% | N/A |
#4 | $4.5M | 43 | -10% | N/A |
#5 | $5.1M | 44 | 0% | N/A |